-
1 Comment
Megasoft Limited is currently in a long term uptrend where the price is trading 43.7% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Technology sector with a price to sales ratio of 0.8.
Megasoft Limited's total revenue sank by 7.1% to $151M since the same quarter in the previous year.
Its net income has dropped by 85.7% to $2M since the same quarter in the previous year.
Finally, its free cash flow grew by 18.5% to $73M since the same quarter in the previous year.
Based on the above factors, Megasoft Limited gets an overall score of 3/5.
| ISIN | INE933B01012 |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Exchange | NSE |
| CurrencyCode | INR |
| PE Ratio | None |
|---|---|
| Market Cap | 5B |
| Target Price | None |
| Beta | 0.91 |
| Dividend Yield | None |
Megasoft Limited does not have significant operations. Previously, the company was engaged in the IT business in India. It focused on pharma, aerospace, and defense electronics areas. Megasoft Limited was founded in 1994 and is based in Hyderabad, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MEGASOFT.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
